🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesHas anyone dealt with surpass-cvot: tirzepatide cardiovascular outcomes trial design? Page 3

Has anyone dealt with surpass-cvot: tirzepatide cardiovascular outcomes trial design?

lori_vegas Tue, Nov 12, 2024 at 6:39 AM 11 replies 1,688 viewsPage 3 of 3
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Nov 13, 2024 at 8:13 AM#11
Dr.GastroMayo said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…

Agreed, with the qualification that SELECT enrolled a secondary-prevention population. Extrapolating a 20% relative reduction to a healthy 35-year-old with a BMI of 31 is not what that trial showed.

39 12FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 36 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Nov 13, 2024 at 10:38 AM#12
alex_tucson said:
True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of…

Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.

40 13Dr.PathRoch, mona_PHX, andrew_nyc and 37 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Nov 13, 2024 at 1:03 PM#13
Dr.GastroMayo said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…

This is where I part company with the consensus forming above. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

41 14HPLC_Greg, LibrarianMeg, bri_stats and 38 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Nov 13, 2024 at 3:28 PM#14

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

42 15amsterdam_pete, LondonLisa, mike_nyc and 39 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Nov 13, 2024 at 5:53 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Carry on.

43 16PurityPaulOR, MaxMetOK, MounjBrad and 40 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register